At-Home Treatment of Patients with Acute Attacks of Hereditary Angioedema with the Bradykinin B2 Receptor-Antagonist Icatibant

被引：1
|
作者：
Farkas, H. [1 ]
Csuka, D. [1 ]
Zotter, Z. [1 ]
Varga, L. [1 ]
Boeroecz, Z. [1 ]
Temesszentandrasi, G. [1 ]
Karadi, I. [1 ]
机构：
[1] Semmelweis Univ, Budapest, Hungary
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2011年 / 127卷 / 02期
关键词：
D O I：
10.1016/j.jaci.2010.12.926
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：AB233 / AB233
页数：1
相关论文
共 50 条
  • [21] Treatment of hereditary angioedema with normal C1-inhibitor with icatibant, a selective bradykinin B2 receptor antagonist
    Bork, K.
    ALLERGY, 2011, 66 : 427 - 428
  • [22] Self-administration of a novel subcutaneous bradykinin b2 receptor antagonist, icatibant, as an effective treatment option in patients with hereditary angioedema
    Santucci S.
    Pham H.
    Harrison R.
    Yang W.
    Allergy, Asthma & Clinical Immunology, 10 (Suppl 2)
  • [23] A novel therapeutic concept for the treatment of acute angioedema attacks in hereditary angioedema patients: multiple successful treatments even in severe swelling attacks with the bradykinin-B2 receptor antagonist Icatibant
    M Bas
    J Greve
    G Kojda
    H Bier
    T Hoffmann
    Critical Care, 10 (Suppl 1):
  • [24] Treatment of Acute Hereditary Angioedema located in the upper aerodigestive tract with Bradykinin-B2-Receptor-Antagonist Icatibant
    Bas, M.
    Greve, J.
    Kojda, G.
    Bier, H.
    Hoffmann, T.
    ALLERGY, 2008, 63 : 348 - 348
  • [25] Proof-of-concept study of icatibant (JE 049), a bradykinin B2 receptor antagonist in treatment of hereditary angioedema.
    Rosenkranz, B
    Bork, K
    Frank, J
    Kreuz, W
    Dong, L
    Knolle, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P14 - P14
  • [26] Successful treatment of ACE inhibitor-induced angioedema with icatibant, a bradykinin B2 receptor antagonist
    Pucar, Phillippa A.
    O'Sullivan, Michael
    Goudie, Adrian
    Marr, Timothy
    Brusch, Anna
    MEDICAL JOURNAL OF AUSTRALIA, 2015, 202 (11) : 596 - 597
  • [27] Icatibant, a New Bradykinin-Receptor Antagonist, in Hereditary Angioedema
    Cicardi, M.
    Banerji, A.
    Bracho, F.
    Malbran, A.
    Rosenkranz, B.
    Riedl, M.
    Bork, K.
    Lumry, W.
    Aberer, W.
    Bier, H.
    Bas, M.
    Greve, J.
    Hoffmann, T. K.
    Farkas, H.
    Reshef, A.
    Ritchie, B.
    Yang, W.
    Grabbe, J.
    Kivity, S.
    Kreuz, W.
    Levy, R. J.
    Luger, T.
    Obtulowicz, K.
    Schmid-Grendelmeier, P.
    Bull, C.
    Sitkauskiene, B.
    Smith, W. B.
    Toubi, E.
    Werner, S.
    Anne, S.
    Bjorkander, J.
    Bouillet, L.
    Cillari, E.
    Hurewitz, D.
    Jacobson, K. W.
    Katelaris, C. H.
    Maurer, M.
    Merk, H.
    Bernstein, J. A.
    Feighery, C.
    Floccard, B.
    Gleich, G.
    Hebert, J.
    Kaatz, M.
    Keith, P.
    Kirkpatrick, C. H.
    Langton, D.
    Martin, L.
    Pichler, C.
    Resnick, D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (06): : 532 - 541
  • [28] Self-Administration Of a Novel Subcutaneous Bradykinin B2 Receptor Antagonist, Icatibant (Firazyr®), As An Effective Treatment Option In Patients With Hereditary Angioedema (HAE)
    Santucci, Stephanie
    Hoang Pham
    Harrison, Rachel
    Yang, William H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB31 - AB31
  • [29] Successful treatment of an acute attack of acquired angioedema with the bradykinin-B2-receptor antagonist icatibant
    Weller, K.
    Magerl, M.
    Maurer, M.
    ALLERGY, 2009, 64 : 155 - 156
  • [30] Successful treatment of an acute attack of acquired angioedema with the bradykinin-B2-receptor antagonist icatibant
    Weller, K.
    Magerl, M.
    Maurer, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2011, 25 (01) : 120 - 120
12345